Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide
Wedel, Hans × McMurray, John J. V Lindberg, Magnus Wikstrand, John Cleland, John G. F Cornel, Jan H Dunselman, Peter Hjalmarson, Ake Kjekshus, John Komajda, Michel Kuusi, Timo Vanhaecke, Johan Waagstein, Finn #
European Journal of Heart Failure vol:11 issue:3 pages:281-291
Aims Few prognostic models in heart failure have been developed in typically elderly patients treated with modern pharmacological therapy and even fewer included simple biochemical tests (such as creatinine), new biomarkers (such as natriuretic peptides), or, especially, both. In addition, most models have been developed for the single outcome of all-cause mortality.